Inhibitory Mechanism of IL-6 Production by Orento in Oral Squamous Cell Carcinoma Cell Line CAL27 Stimulated by Pathogen-Associated Molecular Patterns from Periodontopathogenic Porphyromonas gingivalis

Orento is a traditional Japanese medicinal kampo preparation that is also prescribed in oral care. In oral squamous cell carcinoma cell line CAL27, orento significantly inhibited periodontopathogenic bacterium Porphyromonas gingivalis lipopolysaccharide (LPS) and lipoproteins (PAMP)-stimulated production of interleukin (IL)-6. This suggests that orento negatively regulates PAMP-mediated toll-like receptor (TLR) signaling. Orento significantly suppressed PAMP-stimulated activation of the IL-6 promoter, indicating that orento may suppress the production of IL-6 by PAMP at the transcriptional level. Orento also suppressed TLR-mediated activation of transcription factor nuclear factor-kappa B (NF-kB) that was stimulated by PAMP. This finding indicates that orento may suppress the function and activation of factors involved in TLR signaling, thereby suppressing NF-kB-dependent expression of various genes. Orento suppressed IL-1 receptor-associated kinase (IRAK4), IRAK1, and c-Jun N-terminal kinase (JNK) phosphorylation in PAMP-stimulated CAL27 cells. This result indicates that orento is involved in the initiation of TLR signaling by PAMP and suppresses the downstream signaling pathways of myeloid differentiation primary response gene 88 (MyD88) such as mitogen-activated protein kinase (MAPK) and NF-kB cascades. These findings suggest that orento has an inhibitory effect on the production of inflammatory cytokines.

[1]  D. Bourgeois,et al.  Periodontal Conditions and Pathogens Associated with Pre-Eclampsia: A Scoping Review , 2021, International journal of environmental research and public health.

[2]  Marcus J. Taylor,et al.  MyD88 oligomer size functions as a physical threshold to trigger IL1R Myddosome signaling , 2021, The Journal of cell biology.

[3]  A. Giboreau,et al.  Nutrition as a Key Modifiable Factor for Periodontitis and Main Chronic Diseases , 2021, Journal of clinical medicine.

[4]  T. Hirano.  IL-6 in inflammation, autoimmunity and cancer , 2020, International immunology.

[5]  Y. Makita,et al.  Effect of Orento, a Traditional Japanese Medicine, on IL-6, IL-8 Secretion, Type 1 Collagen Production and Alkaline Phosphatase Secretion in the Human Osteosarcoma Cell Line Saos-2 , 2020, Medicines.

[6]  A. Akhade,et al.  Serum‐borne lipids amplify TLR‐activated inflammatory responses , 2020, Journal of leukocyte biology.

[7]  Michelle L D Snyder,et al.  Cobbling Together the Myddosome. , 2020, Structure.

[8]  R. Genco,et al.  Periodontal disease and cancer: Epidemiologic studies and possible mechanisms , 2020, Periodontology 2000.

[9]  D. Fan,et al.  Biological properties and clinical applications of berberine , 2020, Frontiers of Medicine.

[10]  Yu Chen,et al.  Upregulated-gene expression of Pro-inflammatory cytokines (TNF-α, IL-1β and IL-6) via TLRs following NF-κB and MAPKs in bovine mastitis. , 2020, Acta tropica.

[11]  D. Bourgeois,et al.  Periodontal Pathogens as Risk Factors of Cardiovascular Diseases, Diabetes, Rheumatoid Arthritis, Cancer, and Chronic Obstructive Pulmonary Disease—Is There Cause for Consideration? , 2019, Microorganisms.

[12]  W. Crielaard,et al.  Commensal and Pathogenic Biofilms Alter Toll-Like Receptor Signaling in Reconstructed Human Gingiva , 2019, Front. Cell. Infect. Microbiol..

[13]  M. Azuma,et al.  Effectiveness of Kampo Medicines Against Intractable Stomatitis: A Mini-Review , 2019, International Journal of Medical and Dental Sciences.

[14]  P. Tramini,et al.  Effect of a Toothpaste/Mouthwash Containing Carica papaya Leaf Extract on Interdental Gingival Bleeding: A Randomized Controlled Trial , 2018, International journal of environmental research and public health.

[15]  A. Kaneko,et al.  Introduction to Kampo medicine for dental treatment — Oral pharmacotherapy that utilizes the advantages of Western and Kampo medicines , 2018, The Japanese dental science review.

[16]  A. Lam-ubol,et al.  Toll-like receptor 2 induces adenosine receptor A2a and promotes human squamous carcinoma cell growth via extracellular signal regulated kinases ½ , 2017, Oncotarget.

[17]  C. L. D'hellencourt,et al.  Porphyromonas gingivalis lipopolysaccharides act exclusively through TLR4 with a resilience between mouse and human , 2017, Scientific Reports.

[18]  Y. Imamura,et al.  Salivary protein histatin 3 regulates cell proliferation by enhancing p27(Kip1) and heat shock cognate protein 70 ubiquitination. , 2016, Biochemical and biophysical research communications.

[19]  H. Lan,et al.  Renoprotective effect of berberine on type 2 diabetic nephropathy in rats , 2015, Clinical and experimental pharmacology & physiology.

[20]  M. Costalonga,et al.  The oral microbiome and the immunobiology of periodontal disease and caries. , 2014, Immunology letters.

[21]  Hao Wu,et al.  IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly. , 2014, Molecular cell.

[22]  Ping Ji,et al.  Association of periodontal disease with oral cancer: a meta-analysis , 2014, Tumor Biology.

[23]  T. Pham,et al.  Genetic Exchange of Fimbrial Alleles Exemplifies the Adaptive Virulence Strategy of Porphyromonas gingivalis , 2014, PloS one.

[24]  Y. Imamura,et al.  Salivary histatin 3 inhibits heat shock cognate protein 70-mediated inflammatory cytokine production through toll-like receptors in human gingival fibroblasts , 2014, Journal of Inflammation.

[25]  Ling Wang,et al.  The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice. , 2014, Antioxidants & redox signaling.

[26]  Kaleb M. Pauley,et al.  Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma , 2011, International Journal of Oral Science.